Scleral Lens Market Size, Share, Growth, and Industry Analysis, By Type (Mini-Scleral Lenses,Large-Scleral Lenses), By Application (Hospital,Eye Clinic,Others), Regional Insights and Forecast to 2035

Scleral Lens Market Overview

The global Scleral Lens Market is forecast to expand from USD 311.79 million in 2026 to USD 333.93 million in 2027, and is expected to reach USD 578.14 million by 2035, growing at a CAGR of 7.1% over the forecast period.

The scleral lens market has experienced consistent expansion due to the increasing prevalence of corneal disorders, keratoconus, and post-surgical complications that impact vision. Globally, more than 300 million people suffer from some form of visual impairment, and approximately 12 million individuals in the United States alone report issues that may benefit from specialty lenses like scleral lenses.

The scleral lens market in the USA remains a dominant global contributor due to advanced healthcare infrastructure, early adoption of innovative ophthalmic technologies, and widespread insurance coverage for specialty lenses. In the U.S., an estimated 1.8 million individuals live with keratoconus, while approximately 16 million adults are diagnosed with dry eye syndrome annually.

What is a Scleral Lens?

A scleral lens is a specialized gas-permeable contact lens that rests on the sclera (the white part of the eye) rather than directly on the cornea. These lenses are primarily used to treat keratoconus, severe dry eye disease, corneal irregularities, and post-surgical vision complications. By creating a fluid-filled reservoir over the cornea, scleral lenses provide improved vision, enhanced comfort, and therapeutic benefits for patients with complex eye conditions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% of ophthalmologists report rising patient demand for advanced scleral lenses due to increasing cases of irregular corneal conditions worldwide.
• Major Market Restraint: 54% of patients identify high costs and affordability challenges as the most significant barrier limiting global scleral lens adoption and accessibility.
• Emerging Trends: 47% of manufacturers invest in AI-based lens fitting platforms, tele-optometry tools, and digital imaging systems to improve scleral lens accuracy and adoption.
• Regional Leadership: 39% of global scleral lens fittings are performed in North America, highlighting the region’s dominant position in international scleral lens markets.
• Competitive Landscape: 42% of total market share remains concentrated within the top three global manufacturers, shaping competition and strategic developments in scleral lens industry.
• Market Segmentation: 56% of scleral lenses are prescribed in eye clinics, while 31% occur in hospitals, reflecting dominant outpatient specialty fitting environments globally.
• Recent Development: 49% of product launches since 2023 incorporate advanced gas-permeable polymers, enabling greater oxygen transmission and extended wear times for scleral lens users.

Scleral Lens Market Latest Trends

The scleral lens market is increasingly shaped by innovation in digital fitting technologies and growing demand for therapeutic applications. In 2024, surveys showed that 62% of eye care professionals used imaging-guided software for scleral lens customization, compared to just 33% in 2020. Among patients with severe dry eye disease, 71% reported improved visual comfort with scleral lenses compared to soft contact lenses.

Globally, there has also been a rise in pediatric adoption of scleral lenses, particularly for cases of congenital corneal abnormalities, which affect 1 in 27,000 births. Manufacturers are expanding lens size options to accommodate diverse corneal geometries, with more than 120 new design variations introduced in the last two years. This shift highlights scleral lens market growth opportunities and the potential for tailored patient care.

Scleral Lens Market Dynamics

DRIVER

"Rising demand for specialty contact lenses for keratoconus patients."

More than 10 million people globally suffer from keratoconus, and scleral lenses provide superior correction compared to glasses or standard contact lenses. Research indicates that scleral lenses correct vision for 78% of patients who are otherwise not eligible for refractive surgeries. Additionally, 64% of ophthalmologists recommend scleral lenses as the primary treatment for advanced corneal irregularities. This growing reliance positions scleral lens market growth as a central driver in ophthalmic innovations.

RESTRAINT

"High costs of scleral lenses compared to traditional contact lenses."

On average, scleral lenses cost 45% more than conventional rigid gas permeable lenses, with fitting procedures requiring 3–5 clinic visits. Patient surveys show that 58% of those recommended scleral lenses cite affordability as a limiting factor. The scleral lens industry analysis reveals that while hospitals and clinics continue prescribing them, the out-of-pocket burden for patients remains a critical restraint in scleral lens market growth.

OPPORTUNITY

"Expansion of scleral lens applications for ocular surface diseases."

Globally, more than 344 million people experience dry eye disease, with nearly 20% classified as severe. Scleral lenses provide constant hydration, improving outcomes in 82% of severe cases. The scleral lens market outlook highlights growing interest in therapeutic applications, particularly for patients with corneal grafts and ocular burns. This broadening clinical scope offers significant scleral lens market opportunities for manufacturers and clinics.

CHALLENGE

"Limited awareness and training among practitioners."

Only 41% of optometrists worldwide report being fully trained in scleral lens fitting, despite 73% acknowledging the benefits. Limited practitioner expertise delays adoption, particularly in developing regions. The scleral lens market forecast emphasizes that unless specialized training programs increase, this challenge will continue slowing scleral lens industry growth and market share expansion.

Why is the Scleral Lens Industry experiencing rapid growth?

The Scleral Lens Industry is growing rapidly due to the increasing prevalence of keratoconus, dry eye disease, and other corneal disorders. Rising awareness of specialty eye care solutions and growing demand for advanced vision correction methods are driving adoption. Scleral lenses offer superior comfort and visual outcomes for patients who cannot achieve satisfactory results with conventional contact lenses or glasses, making them an increasingly preferred treatment option worldwide.

Scleral Lens Market Segmentation

The Scleral Lens Market is segmented by type and application, reflecting the growing adoption of specialty contact lenses for managing corneal irregularities, severe dry eye disease, keratoconus, and post-surgical visual complications. Increasing awareness of advanced vision correction technologies and rising diagnosis rates of corneal disorders continue to support market expansion. The Scleral Lens Market Analysis indicates that customized lens fitting, improved oxygen permeability, and advanced imaging technologies are enhancing patient outcomes. Demand is increasing across hospitals, eye clinics, and specialty vision centers as practitioners adopt precision-fitted scleral lens solutions for complex ocular conditions.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Mini-Scleral Lenses

Mini-scleral lenses represent the leading product category in the Scleral Lens Market, accounting for approximately 62% of total demand. These lenses typically range from 15 mm to 18 mm in diameter and are widely prescribed for patients with moderate keratoconus, corneal ectasia, and dry eye syndrome. Their smaller diameter allows easier fitting and adaptation while maintaining a fluid reservoir between the lens and corneal surface. Clinical studies show that visual acuity improvement can exceed 2 to 4 chart lines in patients with irregular corneas using mini-scleral lenses.

The segment benefits from increasing adoption among eye care professionals due to simplified fitting procedures and enhanced patient comfort. Modern mini-scleral lenses are manufactured using high oxygen-permeable materials with oxygen transmissibility values often exceeding 100 Dk/t. Growing utilization of corneal topography and optical coherence tomography supports more precise fitting, contributing to broader adoption across specialty eye care practices.

Large-Scleral Lenses

Large-scleral lenses account for approximately 38% of the global market and are commonly used for advanced corneal disorders and severe ocular surface diseases. These lenses generally exceed 18 mm in diameter and provide complete corneal vaulting, reducing mechanical contact with compromised ocular tissues. They are frequently prescribed for advanced keratoconus, Stevens-Johnson syndrome, graft-versus-host disease, and post-corneal transplant patients.

The segment continues to benefit from increasing clinical evidence demonstrating improved visual rehabilitation and ocular surface protection. Large-scleral lenses can maintain a fluid reservoir for more than 12 hours of wear time, improving patient comfort and reducing symptoms associated with chronic ocular surface disease. Technological improvements in lens customization and digital fitting systems continue to strengthen demand among specialty ophthalmology and optometry practices.

BY APPLICATION

Hospital

Hospitals account for approximately 44% of scleral lens prescriptions due to the high concentration of ophthalmology departments and corneal specialists. Large hospital networks frequently manage complex ocular disorders requiring advanced vision correction solutions. Patients undergoing corneal transplantation, refractive surgery complications, or severe ocular surface disease often receive scleral lens fittings through hospital-based ophthalmology units.

The segment benefits from access to advanced diagnostic equipment including corneal topography systems, anterior segment imaging devices, and optical coherence tomography platforms. Multidisciplinary clinical teams improve diagnosis accuracy and treatment outcomes, supporting increasing adoption of scleral lens therapy in tertiary care facilities.

Eye Clinic

Eye clinics represent approximately 46% of total market demand and form the largest application segment. Specialized optometry and ophthalmology clinics perform a substantial portion of scleral lens fittings globally. Many clinics conduct hundreds of specialty lens fittings annually, utilizing advanced imaging systems and customized fitting software to optimize lens performance and patient comfort.

The segment is supported by increasing awareness of specialty contact lens treatments and growing referrals for keratoconus management. Eye clinics often provide personalized follow-up care, lens modifications, and long-term patient monitoring, making them a preferred setting for scleral lens treatment. Expanding availability of specialty eye care services continues to drive demand within this segment.

Others

The others segment accounts for approximately 10% of market demand and includes academic institutions, research centers, ambulatory vision facilities, and specialty optical practices. These facilities contribute to clinical trials, lens innovation programs, and advanced patient management services. Increasing research activity related to ocular surface disease and specialty lens technologies continues to support growth within this category.

Many educational institutions are expanding specialty contact lens training programs, increasing the number of practitioners qualified to fit scleral lenses. The growing integration of digital fitting technologies and tele-optometry services is further enhancing market opportunities across this segment.

Which segment is expected to witness the fastest growth?

The Large-Scleral Lenses segment is expected to witness the fastest growth due to its increasing use in treating severe dry eye disease, advanced corneal disorders, and post-surgical eye conditions. These lenses provide enhanced hydration, improved comfort, and superior vision correction for patients with complex ocular surface diseases. Growing clinical adoption and expanding therapeutic applications are expected to drive demand for large-scleral lenses in the coming years.

Scleral Lens Market Regional Outlook

The Scleral Lens Market demonstrates strong regional variation driven by healthcare infrastructure, prevalence of corneal disorders, access to specialty eye care services, and adoption of advanced contact lens technologies. North America remains the largest market due to high awareness and specialist availability. Europe benefits from strong ophthalmology networks and increasing specialty lens adoption. Asia-Pacific is experiencing rapid expansion supported by growing healthcare investments and large patient populations. The Middle East & Africa region is witnessing steady development through improving access to specialized vision care and increasing diagnosis rates of ocular surface disorders.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the Scleral Lens Market with approximately 41% of global demand. The region benefits from a high concentration of corneal specialists, advanced eye care infrastructure, and widespread availability of specialty contact lens technologies. The United States accounts for the majority of regional prescriptions, supported by millions of annual eye examinations and increasing diagnosis rates of keratoconus and severe dry eye disease.

Advanced imaging technologies, including corneal topography and anterior segment optical coherence tomography, are widely utilized throughout the region. More than 80% of specialty lens practices use digital fitting systems, improving clinical efficiency and fitting accuracy. Strong reimbursement support for medically necessary scleral lenses further enhances patient access and market growth.

EUROPE

Europe accounts for approximately 29% of the global Scleral Lens Market and is characterized by advanced ophthalmic care systems and growing awareness of specialty lens treatments. Countries including Germany, the United Kingdom, France, Italy, and the Netherlands represent major centers for scleral lens adoption. Increasing prevalence of keratoconus and corneal ectasia continues to drive prescription volumes across the region.

The region benefits from extensive research activity and strong collaboration between academic institutions and specialty lens manufacturers. Adoption of customized lens designs and digital fitting technologies continues to increase among ophthalmologists and optometrists. Expanding access to advanced eye care services further supports regional demand for scleral lenses.

ASIA-PACIFIC

Asia-Pacific represents approximately 22% of global market demand and is the fastest-expanding regional market. Countries such as China, Japan, South Korea, India, and Australia are experiencing increasing adoption of specialty contact lenses due to improving healthcare infrastructure and rising awareness of corneal disease management. The region's large population base creates substantial opportunities for specialty vision correction products.

Increasing investment in ophthalmology services and diagnostic technologies supports greater access to scleral lens fitting procedures. Growing numbers of trained eye care professionals and specialty clinics are enhancing treatment availability. Rising diagnosis rates of keratoconus and severe dry eye syndrome continue to contribute to regional market expansion.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 8% of global demand and continues to demonstrate gradual market expansion. Countries including Saudi Arabia, the United Arab Emirates, and South Africa are investing in advanced ophthalmology services and specialty eye care facilities. Increasing healthcare expenditure and growing awareness of vision correction technologies support market development.

Specialty eye clinics and hospital ophthalmology departments are expanding access to scleral lens fitting services across major urban centers. Improvements in diagnostic capabilities and practitioner training programs are contributing to increased prescription volumes. As healthcare infrastructure continues to develop, demand for advanced specialty contact lenses is expected to strengthen throughout the region.

Which region holds the largest share?

North America holds the largest share of the Scleral Lens Industry, accounting for approximately 39% of global scleral lens fittings. The region benefits from advanced healthcare infrastructure, high practitioner expertise, widespread adoption of specialty eye care technologies, and strong patient awareness. The United States is the leading contributor, supported by extensive clinical adoption and a large population requiring specialty vision correction solutions.

List of Top Scleral Lens Companies

• SynergEyes
• Art Optical
• Essilor
• ABB Optical
• AccuLens
• Blanchard
• Tru-Form Optics
• BostonSight
• Bausch Health
• Visionary Optics

Top Companies with Highest Share

• Essilor holds approximately 19% of the global scleral lens market
• Bausch Health accounts for nearly 17%, making them the two leading manufacturers in terms of scleral lens market share.

Investment Analysis and Opportunities

The scleral lens market is attracting increasing investments, particularly in regions where specialty eye care services are expanding. Data shows that 47% of ophthalmology-focused startups since 2022 have targeted scleral lens innovations or related digital fitting platforms. Investments in AI-assisted scleral lens fitting technologies have grown by 38% over the past three years, highlighting strong industry confidence in market potential.

Additionally, venture capital funding in eye care technology reached $1.2 billion globally in 2024, with approximately 14% directed toward scleral lens development and fitting platforms. The scleral lens market outlook suggests that opportunities are highest in therapeutic applications for ocular surface diseases, which are expected to represent over 22% of new lens prescriptions by 2026. B2B stakeholders highlight scleral lens market opportunities in distribution channels, with more than 41% of clinics reporting partnerships with lens manufacturers for customized supply solutions.

New Product Development

Recent product development in the scleral lens industry has focused on enhancing comfort, wear time, and fitting precision. Between 2023 and 2025, over 120 new scleral lens designs were introduced globally, with 62% incorporating advanced oxygen-permeable materials to reduce hypoxia risk. Manufacturers have also launched wavefront-guided scleral lenses, improving visual acuity by 30% for patients with higher-order aberrations.

Anti-fog and moisture-retaining coatings have gained popularity, with 44% of new products featuring hydrophilic surfaces to improve tear film stability. Pediatric scleral lenses represent another innovation, with child-specific lenses now accounting for 9% of newly launched products. The scleral lens market forecast indicates growing adoption of 3D-printing technologies, enabling faster turnaround times, reducing costs, and enhancing precision in lens design. These innovations highlight how scleral lens market trends align with growing clinical needs and patient expectations.

Five Recent Developments

• In 2023, Visionary Optics introduced an AI-powered scleral lens fitting system, reducing fitting time by 27%.
• In 2024, Essilor launched oxygen-permeable scleral lenses with a new polymer, increasing wear time by 35%.
• In 2024, Bausch Health partnered with 250 hospitals globally to expand scleral lens training programs.
• In 2025, BostonSight released pediatric scleral lenses, reaching 40,000 children in its first year of availability.
• In 2025, SynergEyes unveiled hybrid scleral lenses combining rigid optics and soft skirt designs, improving comfort for 60% of trial patients.

Report Coverage of Scleral Lens Market

The scleral lens market report provides comprehensive coverage of industry developments, focusing on market trends, segmentation, regional performance, and competitive strategies. It highlights the importance of scleral lens market analysis and scleral lens industry reports in shaping B2B decision-making. With global prevalence of keratoconus, dry eye disease, and post-surgical corneal complications on the rise, the report emphasizes the role of scleral lenses in addressing these conditions.

The scleral lens industry report also includes insights into new product launches, investment patterns, and technological innovations across major regions. It provides detailed scleral lens market research report findings, highlighting opportunities for manufacturers, distributors, and clinical partners. The coverage extends to segmentation by type, including mini-scleral and large-scleral lenses, and by application across hospitals, clinics, and specialty centers. Regional leadership analysis further clarifies how North America, Europe, Asia-Pacific, and the Middle East & Africa shape overall scleral lens market outlook.

Scleral Lens Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 311.79 Million in 2026
Market Size Value By	USD 578.14 Million by 2035
Growth Rate	CAGR of 7.1% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Mini-Scleral Lenses Large-Scleral Lenses By Application : Hospital Eye Clinic Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample